These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 2442075

  • 1. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
    Rees JK, Gray R, Hayhoe FG.
    Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075
    [No Abstract] [Full Text] [Related]

  • 2. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK, Gray RG.
    Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
    [No Abstract] [Full Text] [Related]

  • 3. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.
    Marcus RE, Catovsky D, Prentice HG, Newland AC, Chessells JM, Stevens RF, Hann IM, Goldman JM, Hoffbrand AV, Galton DA.
    Haematol Blood Transfus; 1987; 30():346-51. PubMed ID: 2442074
    [No Abstract] [Full Text] [Related]

  • 4. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
    Creutzig U, Ritter J, Riehm H, Budde M, Schellong G.
    Haematol Blood Transfus; 1987; 30():71-5. PubMed ID: 3305225
    [No Abstract] [Full Text] [Related]

  • 5. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
    Creutzig U, Ritter I, Schellong G.
    Gematol Transfuziol; 1991 Jan; 36(1):16-21. PubMed ID: 2065939
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
    Lampkin BC, Woods WG, Buckley JD, Hammond GD.
    Haematol Blood Transfus; 1990 Jan; 33():210-4. PubMed ID: 1691130
    [No Abstract] [Full Text] [Related]

  • 7. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA, Czepulkowski B, Ireland R.
    Leuk Res; 1996 Jan; 20(11-12):987-8. PubMed ID: 9009258
    [Abstract] [Full Text] [Related]

  • 8. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
    Gahrton G, Tidefelt U, Paul C, Björkholm M, Grimfors G, Hast R, Juliusson G, Järnmark M, Killander A, Kimby E.
    Leukemia; 1992 Jan; 6 Suppl 2():89-91. PubMed ID: 1578953
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trial.
    Rees JK, Gray R.
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):32-6. PubMed ID: 3473681
    [Abstract] [Full Text] [Related]

  • 10. Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study.
    Marty M, Lepage E, Guy H, Bordessoule D, Desablens B, Harousseau JL, Guilhot F, Leverger G, Schaison G, Boiron M.
    Haematol Blood Transfus; 1987 Jun; 30():50-6. PubMed ID: 3305217
    [No Abstract] [Full Text] [Related]

  • 11. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
    Berman E, Arlin ZA, Gaynor J, Miller W, Gee T, Kempin SJ, Mertelsmann R, Andreeff M, Reich L, Nahmias N.
    Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
    [Abstract] [Full Text] [Related]

  • 12. Treatment of childhood acute nonlymphocytic leukemia: cooperative Austrian-Hungarian study AML-IGCI-84.
    Fink FM, Gadner H, Grümayer ER, Kardos G, Revesz T, Urban C, Mutz I, Ausserer B, Schuler D.
    Haematol Blood Transfus; 1990 Feb; 33():233-6. PubMed ID: 2182415
    [No Abstract] [Full Text] [Related]

  • 13. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
    Linkesch W, Michlmayr G, Gerhartz H, Illinger H, König H, Düllmann J, Keilhauer R, Moldrzyk D.
    Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
    [Abstract] [Full Text] [Related]

  • 14. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial.
    Goldstone AH, Burnett AK, Wheatley K, Smith AG, Hutchinson RM, Clark RE, Medical Research Council Adult Leukemia Working Party.
    Blood; 2001 Sep 01; 98(5):1302-11. PubMed ID: 11520775
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of acute adult myeloblastic leukemia with intensive chemotherapy].
    Sayas MJ, Sanz MA, Martín-Aragonés G, Javier Rafecas F, Martínez JA, Lorenzo IJ, Sanz GF, Gomis F, Marty ML.
    Sangre (Barc); 1986 Sep 01; 31(6):718-29. PubMed ID: 3470955
    [No Abstract] [Full Text] [Related]

  • 16. Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
    Tan RM, Quah TC, Aung L, Liang S, Kirk RC, Yeoh AE.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):262-7. PubMed ID: 16602120
    [Abstract] [Full Text] [Related]

  • 17. Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
    Lyytikäinen O, Elonen E, Lautenschlager I, Jokipii A, Tiittanen L, Ruutu P.
    Eur J Haematol; 1996 Mar 01; 56(3):188-9. PubMed ID: 8598243
    [No Abstract] [Full Text] [Related]

  • 18. TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen.
    Link H, Kurrle E, Frauer HM, Heil G, Heimpel H, Waller HD, Ostendorf P, Wilms K, Hoelzer D.
    Onkologie; 1986 Jun 01; 9(3):135-8. PubMed ID: 3528958
    [Abstract] [Full Text] [Related]

  • 19. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
    Nowrousian MR, Pfeiffer R, Schaefer UW, Osieka R, Niederle N, Anders C, Schmidt CG.
    Haematol Blood Transfus; 1987 Jun 01; 30():352-5. PubMed ID: 3305206
    [No Abstract] [Full Text] [Related]

  • 20. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M.
    Wiad Lek; 1995 Jun 01; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.